The Making of a cDC1: Precision Programming of Progenitor Potential

Area of Science:

• Immunology
• Developmental Biology
• Genomics

Background:

• Type 1 classical dendritic cells (cDC1s) are crucial immune cells derived from bone marrow progenitors.
• Their development is orchestrated by a complex transcriptional network centered on interferon regulatory factor-8 (IRF8).
• Stage-specific expression of IRF8 is regulated by a super-enhancer and multiple upstream enhancers.

Purpose of the Study:

• To elucidate the intricate transcriptional network governing cDC1 development.
• To understand the role of specific enhancers and transcription factors in lineage commitment.
• To investigate the cis-dependent mechanism regulating enhancer activation during cDC1 differentiation.

Main Methods:

• Analysis of Irf8 enhancer activity during progenitor differentiation.
• Investigation of transcription factor roles (IRF8, C/EBPα, E-proteins, NFIL3, ZEB2, ID2, BATF3, JUN).
• Studies involving compound enhancer deletions to assess cis-dependency.

Main Results:

• A sequential enhancer activation cascade (starting with C/EBPα at +56kb, E-proteins at +41kb, and NFIL3-driven switch to +32kb) controls IRF8 expression.
• NFIL3-mediated suppression of ZEB2 is critical for de-repressing ID2 and BATF3, leading to cDC1 fate.
• The +32kb enhancer utilizes suboptimized elements for BATF3 auto-regulation, crucial for cDC1/cDC2 divergence.
• cis-dependent regulation ensures sequential enhancer function, progressively tuning chromatin accessibility for lineage commitment.
• Disruption of NFIL3/ZEB2 balance or IL-6-induced C/EBPβ can abrogate cDC1 development.

Conclusions:

• cDC1 development is governed by a sequential, cis-regulated enhancer cascade ensuring robust lineage commitment.
• This mechanism provides a novel model for understanding developmental genomic regulation.
• Understanding this pathway is critical for controlling immune cell differentiation and function.